Stock Report

Procter & Gamble Hygiene and Health Care Ltd announces results for the Fourth quarter and Fiscal year ended March 31, 2026

Posted On : 2026-05-28 16:38:46( TIMEZONE : IST )

Procter & Gamble Hygiene and Health Care Ltd. today announced its financial results for the fourth quarter and the fiscal year ended March 31, 2026.

For the Fiscal Year ended March 31, 2026, the Company reported sales of ₹4290 crore, flat versus the same period last year. Profit After Tax (PAT) was ₹857 crores, up 19% versus the comparable period last year, driven by product mix, productivity and efficiency. The Company also announced results for the fourth quarter ended March 31, 2026, with sales at ₹941 crore, down by 5% versus year ago and Profit After Tax (PAT) at ₹153 crore, down by 2% versus the comparable period last year.

Considering that the company, effective last year, changed its Financial Year from July 1 - June 30 to April 1 - March 31, the last Financial Year of the Company covered a period of 9 months, from July 1, 2024, to March 31, 2025. The company performance has therefore been indexed versus the comparable 12-months period in the last year (April 1, 2024, to March 31, 2025). The performance versus a 9-month past fiscal will not be comparable.

V Kumar, Managing Director, Procter & Gamble Hygiene and Health Care Ltd. shared, "We continue to strengthen our focus on consumers through meaningful innovation across our feminine care and healthcare portfolios, while remaining committed to the disciplined execution of our integrated growth strategy - anchored in a focused portfolio, superiority across product performance, packaging, brand communication, retail execution and value, productivity, constructive disruption, and an agile and accountable organization - all directed towards driving sustainable, long-term value creation."

This year's results show targeted investments, with continued focus on consumer centric innovations and strengthening its go-to-market capabilities. During the year, the company amplified communication to increase consumer awareness on the Whisper Period Panty. The company continued to upgrade formulations across many parts of its portfolio, like Whisper Choice and Whisper Bindazzz Nights. In healthcare, the upgraded Vicks VapoRub formulation with Eucalyptus Oil, Menthol and Camphor continued to deliver All-Night Relief for Uninterrupted Sleep. The company is confident that the impact of these initiatives towards addressing the changing consumer needs, positions it for long-term competitiveness.

During the year, the Company continued to contribute to the flagship CSR program of the P&G group, P&G Shiksha, reaffirming its commitment to positively impacting the communities it serves and operates in. Since 2005, P&G Shiksha has supported thousands of schools and communities across the country, impacting over 1 crore children from underserved areas.

The Board of Directors have recommended a final dividend of ₹ 60/- per Equity Share for the Financial Year ended March 31, 2026, subject to the approval of Shareholders of the company at the ensuing 62nd Annual General Meeting. Considering the interim dividend (including one-time special dividend) of ₹195 per share, the total dividend payout for the fiscal will be ₹255 per share, subject to shareholder approval.

Shares of Procter & Gamble Hygiene and Health Care Limited was last trading in BSE at Rs. 10102.80 as compared to the previous close of Rs. 9880.75. The total number of shares traded during the day was 2105 in over 650 trades.

The stock hit an intraday high of Rs. 10399.95 and intraday low of 10056.80. The net turnover during the day was Rs. 21474474.00.